No difference in StAR staining was observed among adenomas with mutations in PRKACA, GNAS, and PRKAR1A. We included five ACAs with GNAS mutations and one with a PRKAR1A mutation in our study; more patients are needed to adequately compare StAR expression among the three mutant groups in future studies. This evidence concerns the gene PRKACA and adenoma.